Readily available drugs and other interventions to potentially improve the efficacy of immune checkpoint blockade in cancer
Merissa Coleman, Sophia J. Mascialino, Anusha Panjwani, Emily Edwards, Vidula V. Sukhatme, Christina Gavegnano, Vikas P. Sukhatme · 2024
Read Readily available drugs and other interventions to potentially improve the efficacy of immune checkpoint blockade in cancer by Merissa Coleman, Sophia J. Mascialino, Anusha Panjwani, Emily Edwards, Vidula V. Sukhatme, Christina Gavegnano, Vikas P. Sukhatme (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10827885.txt.
Description
Merissa Coleman and co-authors review common drugs and other low cost steps that might boost cancer drugs known as immune checkpoint inhibitors. The review appeared in 2023, per the text head. Many of these add ons lack a profit path, so firms rarely fund trials for them, and they stay overlooked.
For each option, the authors give the way it might aid PD-1 blockade, plus data from animal and human studies. They also list common steps that patients on such drugs should avoid. The paper closes with plans for faster trials in patients. Its aim is to push cheap paired options into wider use for cancer care today.
Catalog record
| CREATOR | Merissa Coleman, Sophia J. Mascialino, Anusha Panjwani, Emily Edwards, Vidula V. Sukhatme, Christina Gavegnano, Vikas P. Sukhatme |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |